Ann Tsukamoto of Stem Cells
joined us at World Orphan Drug Congress USA 2015 to present about '
Platform Technology for Rare CNS Diseases'
Download her presentation now to learn about:
HuCNS-SC: First Class in Biologic
HuCNS-SC Pre-Clinical Observations Reflected in Early Clinical Results
Gene Modified Human Neural Stem Cells
Get your copy here!
To find out more about
platform technology for rare CNS diseases
World Orphan Drug Congress USA 2016 April 20-22
in Washington DC.
Remember my details
Privacy statement »
Manage your email preferences »
You will be emailed the document as an attachment (3,412Kb in size)